Q-ReStrain
Formerly Supportive Oligonucleotide Therapy (SOT)
Q-ReStrain is a targeted, individualized therapy developed by the RGCC laboratory. It uses oligonucleotides, short, custom-designed segments of genetic material matched to a specific target identified through your own lab testing. It's delivered as a single IV infusion and remains active in the body for a period of months.
Because each preparation is built around a specific, confirmed target from your own labs, Q-ReStrain is not something ordered off a shelf. It begins with testing and an honest conversation about whether it's a reasonable fit for your situation.
When it fits
Q-ReStrain is one of the tools I consider in certain complex, chronic cases particularly when specialized testing has identified a specific organism worth addressing. Whether it has a role in your situation is something we determine together, after testing.
What the response can feel like
Because Q-ReStrain prompts an active response in the body, it's common to feel worse before you feel steadier. Many people notice temporary, flu-like symptoms in the days after an infusion—fatigue, aches, low-grade fever, or a short-term flare of symptoms they already have. This kind of reaction (sometimes called a Herxheimer, or "Herx," reaction) is generally short-lived, often settling within a few days as the body works through it.
Before your infusion, I'll walk you through what to watch for, what's expected versus what isn't, and when to reach out. We'll have a plan in place for managing symptoms comfortably, and I'll stay in contact with you through the days that follow rather than sending you off on your own.
The Q-ReStrain Procedure
-
Step 01
The patient’s blood is drawn and sent ot the RGCC laboratory.
-
Step 02
RGCC identifies a specific gene sequence from the target and designs a complementary oligonucleotide intended to bind the corresponding mRNA the step by which the preparation is custom-made for that target.
-
Step 03
RGCC ships the preparation back to the clinic, where it is given as an IV infusion (usually about an hour).
One tool, not a promise
Q-ReStrain is an emerging therapy. It has a defined, individualized mechanism, but it is not FDA-approved. I think that's important for you to know up front, in plain terms.
Because of that, I only ever consider it as one precision tool within a much larger, individualized plan, never as a stand-alone treatment. Whether it belongs in your plan is a decision we make together, with the evidence laid out honestly.
Common Questions
-
It's a single IV infusion. Once given, the preparation remains active in the body over a period of months, which is part of why the upfront testing and planning matter so much.
-
Some people experience temporary, flu-like symptoms as the body responds fatigue, aches, low-grade fever, or a short-term flare of existing symptoms. This is generally short-lived. We'll review what to expect beforehand and stay in close contact afterward.
-
No. I only ever consider Q-ReStrain as one part of a broader, individualized plan.
Schedule a Complimentary Consultation
Schedule a complimentary 15-minute discovery call to talk through whether Q-ReStrain has any place in your care.